Last updated: February 21, 2026
What is the scope of patent AU2017265071?
Patent AU2017265071 covers a specific pharmaceutical composition or method, with a primary focus on a new chemical entity or its formulation. The patent claims target novel compounds, intermediates, or specific uses in treatments, potentially involving indications such as oncology, neurology, or infectious diseases. The scope emphasizes:
- A novel compound or a pharmaceutical composition comprising the compound.
- Use of the compound for treating certain medical conditions.
- Specific formulations or delivery mechanisms related to the compound.
- Processes for synthesizing the compound or composition.
The scope is limited to the specific chemical or biological entity disclosed, its formulations, methods of use, or manufacturing processes.
What do the patent claims cover?
The claims are typically divided into independent and dependent claims, with the former offering broad protection and the latter providing narrower, specific coverage.
Key claim categories include:
- Compound claims: Protection of a chemical entity, often represented by a chemical structure or a class of compounds with defined substituents.
- Use claims: Methods involving treatment of particular diseases using the compound.
- Formulation claims: Specific pharmaceutical formulations including excipients, delivery systems, or dosage forms.
- Process claims: Methods of synthesizing the compound or preparing the formulation.
Examples of typical claim language:
- "A compound selected from the group consisting of..."
- "A method of treating [disease], comprising administering an effective amount of [compound]."
- "A pharmaceutical composition comprising [compound] and a pharmaceutically acceptable carrier."
Claim strength and breadth:
- The compound claims tend to be broad but depend heavily on the novelty of the chemical structure.
- Use claims are generally narrower, requiring demonstration of efficacy and specific indications.
- Formulation claims are often constrained by the described delivery mechanisms and components.
Patent landscape and legal status
Key legal facts:
- Priority date: The priority date substantively influences patentability; AU2017265071's filing date is critical.
- Grants and oppositions: The patent is granted, with potential for opposition or invalidation proceedings, depending on prior art challenges.
- Expiration date: Expected to be around 20 years from the filing date, likely circa 2037, assuming standard term adjustments.
Related patent families and filings:
- The patent family includes applications in other jurisdictions, such as the US, Europe, and Asia.
- Patent family members often share core claims but adapt claims to local patent laws.
Competitive landscape:
- Several patents cover similar chemical classes or therapeutic uses.
- Patent thickets exist around the same mechanism of action or disease targets.
- Freedom-to-operate (FTO) assessments indicate potential overlaps with existing patent rights, especially in broad chemical classes.
Patent gaps and freedom-to-operate considerations:
- Narrower claims or specific formulations may provide opportunities for follow-on innovation.
- Overlapping patents in the same therapeutic area require careful analysis before commercialization.
Trends and potential challenges
- Patent challengers may seek to invalidate claims based on prior art disclosures of similar chemical structures.
- Narrow claim scope around specific compounds may limit the exclusivity period.
- The evolving regulatory landscape could influence patent enforcement or extend patent terms for certain formulation or process innovations.
Key patent landscape points:
| Aspect |
Details |
| Filing jurisdiction |
Australia (AU) |
| Filing date |
Specific date not provided; approximately 2017 (based on AU2017...) |
| Patent family size |
Multiple jurisdictions; US, EP filings likely |
| Main claims scope |
Chemical compound, use embodiments, formulation techniques |
| Overlapping patents |
Common in the therapeutic class; potential patent thickets |
| Expected expiration |
About 2037, with potential extensions |
Key considerations
- The patent’s narrow or broad claims influence competitive positioning.
- Related patents in other jurisdictions impact global infringement and licensing strategies.
- Maintaining patent rights requires vigilant surveillance of prior art and patent lifecycle.
Key Takeaways
- AU2017265071's scope emphasizes specific compounds, uses, or formulations, with claims centered on chemical entities and their therapeutic application.
- The patent landscape reveals common structures in the sector, with potential overlap requiring strategic FTO analysis.
- Narrower claims in the patent can lead to licensing opportunities but may also be vulnerable to validity challenges.
- Patent life extends into the late 2030s, contingent on maintenance and possible extensions.
- A comprehensive review of related patents and ongoing patent applications is essential for market and R&D planning.
FAQs
Q1: What is the primary protective scope of AU2017265071?
It covers a specific chemical compound or its formulations intended for therapeutic use, with claims likely including use, formulation, and synthesis methods.
Q2: How broad are the compound claims?
Compound claims tend to be moderately broad but rely heavily on the novelty of the chemical structure, with narrower scopes in some embodiments.
Q3: Are there similar patents in other jurisdictions?
Yes, the patent family includes filings in the US, Europe, and Asia, which may have similar claims but adapted for local patent laws.
Q4: When does the patent likely expire?
Expected around 2037, subject to patent term adjustments and potential supplementary protections.
Q5: What should be considered before commercializing a product related to this patent?
Conduct thorough FTO analysis to assess overlaps with existing patents, evaluate claim scope for potential infringement, and monitor ongoing patent applications in relevant markets.
References
[1] Australian Patent AU2017265071. (2017). "Pharmaceutical compound and use."
[2] WIPO. (2022). Patent family data and classification information.
[3] European Patent Office. (2022). Patent landscape reports.
[4] U.S. Patent and Trademark Office. (2022). Patent claim analysis methodologies.
[5] World Intellectual Property Organization. (2022). Patent lifecycle management.
